Bexsero

BIOLOGICAL7 trials

Conditions

Genital HerpesGonococcal Infections Gonococcal InfectionsGonorrheaGonorrhea of AnusGonorrhea of CervixGonorrhea of PharynxInfections, MeningococcalMeningococcal Vaccine

Phase 1

A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults

CompletedNCT02491463

GlaxoSmithKlineRespiratory Synctial Virus Infections

Start: 2015-07-23End: 2017-01-26Updated: 2018-08-20

A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes

CompletedNCT06033261

ModernaTX, Inc.Genital Herpes

Start: 2023-09-06End: 2025-04-25Updated: 2025-05-08

Phase 2

Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

CompletedNCT02212457

GlaxoSmithKlineInfections, Meningococcal

Start: 2014-08-21End: 2016-03-03Updated: 2019-06-27

A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants

TerminatedNCT04645966

PfizerMeningococcal Vaccine

Start: 2020-11-26End: 2022-09-15Updated: 2024-03-25

Meningococcal B Vaccine in Patients with Asplenia

RecruitingNCT06025487

Medical University of ViennaSplenectomy; Status

Start: 2024-03-12End: 2025-12-31Target: 80Updated: 2024-11-22

Phase 3

BIYELA - Bexsero Immunisation in Young Women in Africa

Active, not recruitingNCT06446752

University of WashingtonGonorrhea, Gonorrhea of Anus, Gonorrhea of Cervix +1

Start: 2024-08-14End: 2027-01-31Updated: 2025-07-10

Unknown Phase

Gonococcal Vaccine Research

Active, not recruitingJPRN-jRCTs031240617

Aoki TakahiroGonococcal Infections Gonococcal Infections

Start: 2025-04-01Target: 800Updated: 2025-07-18

Related Papers

Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents

Human Vaccines & Immunotherapeutics2021-09-2810 citations

7. Two-Dose 4CMenB Vaccination in Adolescents Elicits a Bactericidal Activity against 15 Outbreak-Representative Meningococcal Strains

Open Forum Infectious Diseases2020-10-01

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults

Clinical Infectious Diseases2019-07-2356 citations